Physostigmine in the Treatment of y-Hydroxybutyric Acid Overdose
Publication
, Journal Article
Yates, SW; Viera, AJ
Published in: Mayo Clinic Proceedings
January 1, 2000
The widespread abuse of the recreational drug γ-hydroxybutyric acid has resulted in several reports of overdose leading to coma. The use of a short-acting anticholinesterase agent such as physostigmine as a potential reversal agent has been proposed previously. We report 2 cases of γ-hydroxybutyric acid-induced coma that rapidly reversed with intravenous administration of physostigmine. © 2000 Mayo Foundation for Medical Education and Research.
Duke Scholars
Published In
Mayo Clinic Proceedings
DOI
ISSN
0025-6196
Publication Date
January 1, 2000
Volume
75
Issue
4
Start / End Page
401 / 402
Related Subject Headings
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Yates, S. W., & Viera, A. J. (2000). Physostigmine in the Treatment of y-Hydroxybutyric Acid Overdose. Mayo Clinic Proceedings, 75(4), 401–402. https://doi.org/10.4065/75.4.401
Yates, S. W., and A. J. Viera. “Physostigmine in the Treatment of y-Hydroxybutyric Acid Overdose.” Mayo Clinic Proceedings 75, no. 4 (January 1, 2000): 401–2. https://doi.org/10.4065/75.4.401.
Yates SW, Viera AJ. Physostigmine in the Treatment of y-Hydroxybutyric Acid Overdose. Mayo Clinic Proceedings. 2000 Jan 1;75(4):401–2.
Yates, S. W., and A. J. Viera. “Physostigmine in the Treatment of y-Hydroxybutyric Acid Overdose.” Mayo Clinic Proceedings, vol. 75, no. 4, Jan. 2000, pp. 401–02. Scopus, doi:10.4065/75.4.401.
Yates SW, Viera AJ. Physostigmine in the Treatment of y-Hydroxybutyric Acid Overdose. Mayo Clinic Proceedings. 2000 Jan 1;75(4):401–402.
Published In
Mayo Clinic Proceedings
DOI
ISSN
0025-6196
Publication Date
January 1, 2000
Volume
75
Issue
4
Start / End Page
401 / 402
Related Subject Headings
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences